Decreased Risk of Renal Allograft Thrombosis Associated With Interleukin-2 Receptor Antagonists: A Report of the NAPRTCS
Authors:
Open Access
- 1 March 2006
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 6 (3) , 585-588
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Pretransplant peritoneal dialysis and graft thrombosis following pediatric kidney transplantation: A NAPRTCS reportPediatric Transplantation, 2003
- Changes in coagulation and fibrinolysis in the postoperative period immediately after kidney transplantation in patients receiving OKT3 or cyclosporine A as induction therapyAmerican Journal of Kidney Diseases, 1998
- RISK FACTORS FOR VASCULAR THROMBOSIS IN PEDIATRIC RENAL TRANSPLANTATIONTransplantation, 1997
- Effects of interleukin‐2 administration on platelet function in cancer patientsAmerican Journal of Hematology, 1994
- Renal Transplantation in ChildrenNew England Journal of Medicine, 1992
- Induction of thromboses within renal grafts by high-dose prophylactic OKT3The Lancet, 1992
- GRAFT THROMBOSIS IN PEDIATRIC RENAL TRANSPLANT RECIPIENTSTransplantation, 1991
- ALLOGRAFT RENAL VASCULAR THROMBOSIS-LACK OF INCREASE WITH CYCLOSPORINE IMMUNOSUPPRESSIONTransplantation, 1989
- Cyclosporine A enhances platelet aggregationKidney International, 1987
- THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTSThe Lancet, 1985